PharVision Advisers’s TTEC Holdings TTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,117
Closed -$27.4K – 72
2026
Q2
$27.4K Sell
14,117
-14,457
-51% -$37.4K 0.52% 62
2026
Q1
$71.4K Buy
+28,574
New +$81.8K 0.72% 71
2025
Q4
– Sell
-88,491
Closed -$297K – 1011
2025
Q3
$297K Buy
+88,491
New +$363K 0.17% 231

Other funds holding TTEC

PharVision Advisers's TTEC Position: Q3 2026 in Review

PharVision Advisers sold out of TTEC Holdings (TTEC) in Q3 2026, closing a stake of 14,117 shares — an estimated $27.4K sold.

PharVision Advisers first reported a position in TTEC in Q3 2025 and held it in 3 quarters. The position peaked at $297K in Q3 2025. 20 funds tracked by Wall St. Rank hold TTEC as of Q3 2026.

  • PharVision Advisers reported no remaining TTEC Holdings position as of Q3 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,117 TTEC Holdings shares in Q3 2026, an estimated $27.4K.
  • PharVision Advisers first reported a position in TTEC Holdings in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's TTEC Holdings position peaked at $297K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held TTEC Holdings as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.